EMA Authorised: Brintellix (vortioxetine) — H. Lundbeck A/S

View source ↗

Summary

The European Medicines Agency authorised Brintellix (vortioxetine) by H. Lundbeck A/S for major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Brintellix (vortioxetine)

Snippet

Status: Authorised. Therapeutic area: Depressive Disorder, Major. MAH: H. Lundbeck A/S. Decision date: 27/11/2025